Data regarding antiviral immune responses in kidney transplant recipients (KTRs) to newer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron lineages after 4 monovalent messenger RNA (mRNA) vaccine doses are limited. To address that, we conducted a prospective single-center observational cohort study of KTRs who had previously received 3 SARS-CoV-2 monovalent mRNA vaccines (mRNA-1273 or BNT162b2) and collected samples before and 1 mo after the fourth monovalent vaccine dose.

Among selected patients with type 2 diabetes mellitus (T2DM), simultaneous pancreas and kidney (SPK) transplants can be an effective option. However, data are limited about outcomes in T2DM SPK recipients based on the pretransplant C-peptide levels.

We aimed to facilitate the donation of tissue samples for research by establishing a centralized system integrated in the organ donation program for collection, storage, and distribution of samples (the Australian Donation and Transplantation Biobank [ADTB]).

Urinary tract infections (UTIs) are prevalent in renal transplant (RTX) recipients and associated with worse outcomes. Early detection by sensitive diagnostic tests and appropriate treatment strategies in this cohort is therefore crucial, but evidence has shown that current methods may miss genuine infections. Research has shed light on the urinary tract microbial ecology of healthy individuals and nontransplant patients with UTI, but information on the RTx cohort is scant. We conducted a cross-sectional study to (i) compare the gold standard diagnostic culture with alternative techniques and (ii) characterize RTx patient urinary microbial communities.